Psychedelic DMT tested as painkiller in small human trial
NCT ID NCT06180759
First seen Apr 07, 2026 · Last updated Apr 28, 2026 · Updated 3 times
Summary
This study looked at whether DMT, a psychedelic drug, can reduce pain in healthy people. Seventeen volunteers received DMT, ketamine (a known painkiller), or a placebo, and then had mild pain caused by electrical stimulation. The goal was to measure how well DMT blocks pain, including unusual pain like allodynia (pain from light touch). The results will help guide future research on psychedelics for chronic pain conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Pharmacology & Toxicology, University Hospital Basel
Basel, Basel, 4056, Switzerland
Conditions
Explore the condition pages connected to this study.